Purpose: The Study Start-Up (SSU) Lead independently leads the planning and execution of global SSU activities for multiple medium to complex global studies of high priority to ensure timely trial document and task completion to enable country HA (Health Authorities) and Ethics Committee submissions and site activation to meet ambitious recruitment plans. The Study Start-Up Lead works collaboratively with other key CTT members and leads the SSU Team (CTT sub-team / 20+ members across multiple countries) comprised of the country SSU Management, Vendor Management, Regulatory, Grants and Contracts, Translations, Document Management, Clinical Supplies, and others as needed to accelerate study, country, and site activation.

Accountabilities

Early Planning and Team Leadership:

• Responsible for all Study Start-Up (SSU) activities for medium to highly complex high priority studies.
• Independent decisions for all study start-up activities.
• Full responsibility to independently deliver SSU insights to the development of the trial Operational Execution Plan (OEP) and aligns the SSU plan and strategy accordingly as reflected in SSU systems, milestones and dashboards with Study Leader /Clinical Trial Team (CTT).
• Configures and ensures proper trial-specific set-up of SSU systems (e.g., Expected Document Lists, eTMF, milestones, tasks, personnel, vendors, languages/translations, confirmed and back-up countries, CTMS (Clinical Trial Management System), enrollment plan, vendor management tool, site contracting and budgeting tool, ICF template tool, etc.)
• Autonomously strategizes global SSU planning and leads SSU Team (CTT sub-team) from kick-off through completion of SSU (all countries and 95% sites enrolling or as defined per trial)
• Implements global aspects of protocol and OEP amendments, activates and oversees country implementation of amendments as determined per trial and in conjunction with Study Leader.

Leads Global SSU Activation:

• Responsible for global trial level document readiness (including vendor and IMP (INVESTIGATIONAL MEDICINAL PRODUCT) and collection into eTMF as necessary for country health authority and Ethics Committee submission and site activation
• Guides the Vendor Program Manager (VPM) as needed to ensure timely global vendor activation and HA submission documents
• Ensures Protocol and ICF (Informed Consent Form) global trial template is ready for country usage as necessary including translations
• Drives transparency of timelines of global SSU deliverables with SSU Managers to ensure country alignment and efficiency
• Directs the Study Grants Expert for investigator grant plan/fair market value assessment initiation and finalization of country site budget and contract template readiness in conjunction with protocol timelines
• Global accountability of timelines, accuracy, and quality of global TMF (Trial Master File) documents in study start-up to ensure TMF inspection readiness
• Ensure proactive oversight and risk management for SSU team activities to achieve start-up timelines and quality execution, proposing and implementing corrective actions where appropriate, according to Novartis standards and local and international regulations
• Collaborates with GCS (Global Clinical Supply) to ensure coordination and readiness of global clinical supply
• Ensures the use and date completeness/accuracy of applicable technology platforms during SSU

Accountable for country SSU:

• Coaches the country Study Start-up Managers to drive timely start-up activities from country allocation to “Ready to Enroll” within assigned medium to complex trials
• Provides oversight and support to country Study Start-up Managers as needed to ensure that study start-up activities are conducted and completed to plan, including set-up and usage of tools/systems, timely delivery of SSU deliverables (e.g.  IRB/IEC submission packages, Informed Consent review, local submission package for submission to IRB/IEC, CTA (Clinical Trial Application) Hub (Europe: acc. to new EU-CTR) as well as Health Authorities and adherence to process standards.
• Guides the VPM as needed to ensure global vendor activation and site readiness in collaboration with to meet site activation timelines/plan.
• Ensure global deliverables to enable site initiation readiness is in place for initial drug release
• Responsible for all global and country budget (TCF (Trial Commitment Forms)) processes and approvals support SSU activities and timelines

Activities & Interfaces:

• Successful and timely completion of global study start-up activities through the activation of all countries and 95% of sites active
• Accountable for initial trial deliverables to agreed timelines and milestones.

Key Performance Indicators:

• Consistent, data driven SSU process delivery to plan at or above 25th percentile of KMR cycle times (6-month reduction of FP (Final Protocol) to LPFV (Last Patient First Visit))
• High quality, timely SSU deliverables/documentation/data in adherence to prevailing legislation, ICH/GCP, IRB/IEC, Health Authority and SOP (Standard Operation Procedure) requirements

Experience:

• Minimum 3 years' experience in project management, in clinical operations in a role that oversees (project management) and/or with monitoring clinical trials
• Minimum 2 years of contribution to and accomplishment in all aspects of conducting clinical trials (e.g., planning, executing, reporting and publishing) in a global/matrix environment in pharmaceutical industry or a contract research organization  

IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. We believe in pushing the boundaries of human science and data science to make the biggest impact possible – to help our customers create a healthier world. Learn more at https://jobs.iqvia.com

We are committed to providing equal employment opportunities for all, including veterans and candidates with disabilities. https://jobs.iqvia.com/eoe

IQVIA’s ability to operate and provide certain services to customers and partners necessitates IQVIA and its employees meet specific requirements regarding COVID-19 vaccination status.https://jobs.iqvia.com/covid-19-vaccine-status